TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / SPONSORED ADS
Shares, excl. options Q1 2024
72.4 M
Holdings value Q1 2024
$1.01 B
Value change Q1 2024
-$72.1 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
296
Number of buys Q1 2024
149
Number of sells Q1 2024
-111
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
-0.002%
CUSIP
874060205
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 72.4 M $1.01 B -$72.1 M $13.89 296
2023 Q4 78.3 M $1.12 B +$44.4 M $14.27 293
2023 Q3 79.9 M $1.23 B -$62.6 M $15.47 300
2023 Q2 83.7 M $1.32 B -$50.1 M $15.71 300
2023 Q1 81.6 M $1.34 B +$255 M $16.48 288
2022 Q4 67.5 M $1.05 B +$60.4 M $15.60 265
2022 Q3 59.2 M $768 M +$94.4 M $12.97 246
2022 Q2 56.3 M $791 M +$69.1 M $14.04 245
2022 Q1 55.6 M $795 M -$259 M $14.32 259
2021 Q4 70.1 M $956 M -$283 M $13.63 263
2021 Q3 91.2 M $1.49 B -$41.6 M $16.38 264
2021 Q2 94.5 M $1.59 B -$224 M $16.83 281
2021 Q1 107 M $1.94 B -$5.54 M $18.26 293
2020 Q4 108 M $1.97 B +$47.7 M $18.20 281
2020 Q3 107 M $1.9 B -$77.9 M $17.84 287
2020 Q2 110 M $1.97 B -$82.8 M $17.93 283
2020 Q1 115 M $1.74 B -$256 M $15.18 273
2019 Q4 129 M $2.54 B -$263 M $19.73 309
2019 Q3 141 M $2.43 B -$10.1 M $17.20 283
2019 Q2 143 M $2.53 B -$492 M $17.70 312
2019 Q1 174 M $3.55 B +$2.48 B $20.37 353
2018 Q4 53.5 M $903 M +$834 M $16.82 82
2018 Q3 2.92 M $62.3 M +$9.17 M $21.37 14
2018 Q2 2.49 M $52.1 M +$10.8 M $20.90 12
2018 Q1 1.88 M $46 M +$5.62 M $24.55 8
2017 Q4 1.65 M $47 M +$7.83 M $28.30 7
2017 Q3 1.38 M $38.1 M +$9.51 M $27.54 6
2017 Q2 1.03 M $26.3 M +$3.29 M $25.42 5
2017 Q1 904 K $21.3 M +$7.3 M $23.63 5
2016 Q4 598 K $12.4 M +$280 K $20.78 6
2016 Q3 584 K $14 M +$3.23 M $23.88 4
2016 Q2 450 K $9.68 M -$5.84 M $21.54 6
2016 Q1 721 K $16.4 M +$3.73 M $22.82 7
2015 Q4 557 K $14 M +$8.51 M $25.02 8
2015 Q3 232 K $5.06 M -$7.91 M $21.88 8
2015 Q2 556 K $13.5 M +$636 K $24.16 7
2015 Q1 530 K $13.3 M +$1.84 M $25.00 8
2014 Q4 456 K $9.48 M -$83.6 K $20.84 8
2014 Q3 460 K $10 M +$531 K $21.75 8
2014 Q2 436 K $10.1 M -$6.9 M $23.19 7
2014 Q1 726 K $17.2 M +$5.03 M $23.75 9